Best DTx - Pediatrics Products

EndeavorRx is an ADHD treatment for kids aged 8-12. It’s delivered through an immersive video game experience on mobile devices. Created by world-class neuroscientists and award-winning game designers, it targets areas of the brain that play a key role in attention function. As an FDA-authorized medical device, EndeavorRx must be prescribed by a healthcare professional. It should be considered for use as part of a therapeutic program.

Cognoa is developing digital products intended to support healthcare providers in expediting diagnosis with the goal of improving access to timely intervention for children and families, starting with autism spectrum disorder (ASD).

Cogo Attention Training Programme is a digital solution provided by Neeuro. Paired with the Neero SenzeBand 2, it encompasses several categories of digital health solutions including Digital Therapeutics (DTx) and DIY Care.

Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics

Digital Therapeutics​ - Cogo Attention Training Programme

Cogo is a patented, scientifically validated digital therapeutic and attention training programme based on Brain-Computer Interface (BCI) technology, suitable for 6 to 12 years old children who exhibit inattentive symptoms. It is jointly developed by A*STAR’s Institute for Infocomm Research (I2R), Institute of Mental Health, and Duke-NUS Medical School in Singapore through a decade of research and clinical trials. 

Paired with Neeuro SenzeBand 2, the Cogo Attention Training Programme is a 24-session programme. Practitioners can supervise the child's progress either at the clinic or through an online dashboard where the session achievements are tracked. Parents can also receive a progress report as the child completes different sessions. The programme can be completed within 2 to 3 months, at 2 or 3 sessions per week, 30 minutes per session. 

Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics

Neeuro SenzeBand 2​

The Neeuro SenzeBand 2 is a non-invasive device for capturing EEG (brainwaves) signals. It consists of 7 dry electrodes with five located on the prefrontal cortex and two on the sides. Together with Neeuro’s machine learning algorithms, it interprets these EEG signals into various mental states, like attention, relaxation, mental workload, fatigue, stress, and many more. This provides insightful biofeedback for measurements used in real-time to drive interventions for various brain health challenges.

Smileyscope pioneered and patented a powerful new approach to digital therapeutics – virtual reality neuromodulation. 

Smileyscope's innovative therapeutic platform underwent rigorous clinical studies, and has changed pediatric needle practice worldwide. International vascular access guidelines now recommend Smileyscope.

SparkRx provides the core components of behavioral activation therapy to young people with symptoms of depression. The 5-week program provides clinicians with an immediate and safe adjunct treatment option they can offer their patients. SparkRx is delivered via smartphone app, and includes features such as psychoeducation, activity scheduling, mood tracking, and mindfulness.

We offer a personalised approach to improve patient outcomes and empower ill children to live healthier lives by delivering digital therapeutics through a mobile game. Our aim is to become the global leader in digital therapeutics for pediatric patients. Triumf was named as the TOP digital health company in Europe in 2019 and in TOP20 across all industries in Europe. The company combines game environment and validated psychological theories for children to monitor and support their well-being in a personalized manner by using machine learning. The data from the game is analyzed and gathered to a dashboard for the care team to improve treatment monitoring, medical visit effectiveness and patient-doctor communication. Digital health interventions such as the Triumf game have great potential to act as health improving scalable tools by contributing to the effectiveness, accessibility and personalisation of healthcare delivery. However, digital solutions need to be evaluated using scientific methodology to prove their effectiveness and safety. We completed a multi-site clinical study in 2018 among pediatric cancer patients and showed that Triumf digital health intervention has a positive effect on players emotional state and health related quality of life. We showed that the total acceptability percentage of the game was 86%. Importantly, 100% answered that the game was easy to use and the content and information was useful and trustworthy. Furthermore, 100% would recommend the game to a friend. By comparing pre-study and post-study mean scores of mental wellbeing and quality of life, we found improvements in mental health and health related quality of life. We have proven that play is the way to healthier life. The research is now published in the digital journal JMIR. Randomised control trials amongst pediatric diabetes patients and children undergoing surgery are currently ongoing in Singapore, Estonia and Finland. Triumf mobile health game is available for Android operating system and it features paths for kids with 1. cancer; 2. diabetes; 3. asthma 4.weight problems 5.surgery. It is available in English, Russian, Finnish and Estonian languages (Spanish in pipeline).